Narrative review / 2020
A review of 21 biomonitoring studies indicates upper-bound human glyphosate exposures may be closer to acceptable daily intake values than previously estimated.
Researchers reviewed and compared results from 21 studies using human biomonitoring to measure urinary glyphosate and AMPA across occupational, environmental, and vulnerable groups. Exposure levels were difficult to elucidate due to variations in sampling strategies, analytical methods, and data presentation. While back-calculations based on animal-derived excretion rates suggested no health concerns relative to EFSA ADI values, recent human metabolism data reported urinary excretion rates as low as 1%. Extrapolations from urinary concentrations using this rate suggest upper-bound exposure levels may be much closer to the ADI than previously reported.
- Study type
- Narrative review of human biomonitoring studies
- Who was studied
- Human populations across 21 studies, including occupational, environmental, and vulnerable groups (e.g., children)
- What was measured
- Urinary levels of glyphosate and aminomethylphosphonic acid (AMPA), and extrapolated exposure doses relative to acceptable daily intake (ADI)
THE PAPER
Human Biomonitoring of Glyphosate Exposures: State-of-the-Art and Future Research Challenges.
Connolly A, Coggins MA, Koch HM. Toxics, 2020.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.